Clayton AH - Search Results

1

Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.

Althof S, Derogatis LR, Greenberg S, Clayton AH, Jordan R, Lucas J, Spana C. Althof S, et al. Among authors: clayton ah. J Sex Med. 2019 Aug;16(8):1226-1235. doi: 10.1016/j.jsxm.2019.05.012. Epub 2019 Jul 2. J Sex Med. 2019. PMID: 31277966 Clinical Trial.

2

The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.

Sills T, Wunderlich G, Pyke R, Segraves RT, Leiblum S, Clayton A, Cotton D, Evans K. Sills T, et al. J Sex Med. 2005 Nov;2(6):801-18. doi: 10.1111/j.1743-6109.2005.00146.x. J Sex Med. 2005. PMID: 16422805

3

Clinical evaluation and management strategy for sexual dysfunction in men and women.

Hatzichristou D, Rosen RC, Broderick G, Clayton A, Cuzin B, Derogatis L, Litwin M, Meuleman E, O'Leary M, Quirk F, Sadovsky R, Seftel A. Hatzichristou D, et al. J Sex Med. 2004 Jul;1(1):49-57. doi: 10.1111/j.1743-6109.2004.10108.x. J Sex Med. 2004. PMID: 16422983

4

The other side: failure in fair and balanced reporting.

Althof SE, Goldstein I, Becher E, Giraldi A, Vardi Y, Dennerstein L, Marson L, Brotto L, Schreiner-Engel P, Wallen K, Clayton A, Altman A, Kingsberg S, Shabsigh R; Board of Directors of the International Society for the Study of Women's Sexual Health. Althof SE, et al. J Sex Med. 2005 Jul;2(4):583-4. J Sex Med. 2005. PMID: 16432924 No abstract available.

5

Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs.

Warnock JK, Clayton A, Croft H, Segraves R, Biggs FC. Warnock JK, et al. J Sex Med. 2006 Sep;3(5):878-882. doi: 10.1111/j.1743-6109.2006.00294.x. J Sex Med. 2006. PMID: 16942531

6

Proposal for changes in diagnostic criteria for sexual dysfunctions.

Segraves R, Balon R, Clayton A. Segraves R, et al. J Sex Med. 2007 May;4(3):567-580. doi: 10.1111/j.1743-6109.2007.00455.x. Epub 2007 Apr 13. J Sex Med. 2007. PMID: 17433086 Review.

7

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Clayton A, et al. J Sex Med. 2007 Jul;4(4 Pt 1):917-29. doi: 10.1111/j.1743-6109.2007.00520.x. J Sex Med. 2007. PMID: 17627739 Clinical Trial.

8

Epidemiology and neurobiology of female sexual dysfunction.

Clayton AH. Clayton AH. J Sex Med. 2007 Nov;4 Suppl 4:260-8. doi: 10.1111/j.1743-6109.2007.00609.x. J Sex Med. 2007. PMID: 17958618 Review.

9

Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder.

Derogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Derogatis L, et al. J Sex Med. 2008 Feb;5(2):357-64. doi: 10.1111/j.1743-6109.2007.00672.x. Epub 2007 Nov 27. J Sex Med. 2008. PMID: 18042215

10

Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study.

Harsh V, McGarvey EL, Clayton AH. Harsh V, et al. Among authors: clayton ah. J Sex Med. 2008 Mar;5(3):640-5. doi: 10.1111/j.1743-6109.2007.00746.x. Epub 2008 Jan 10. J Sex Med. 2008. PMID: 18194180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page